The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use
Open accessAbstract
Points• Systematic reviews are most commonly based on aggregate data extracted from publications or obtained from trial investigators.• Systematic reviews involving the central collection and analysis of individual participant data (IPD) usually are larger-scale, international, collaborative projects that can bring about substantial improvements to the quantity and quality of data, give greater scope in the analyses, and provide more detailed and robust results.• The process of collecting, checking, and analysing IPD is more complex than for aggregate data, and not all IPD meta-analyses are done to the same standard, making it difficult for researchers, clinicians, patients, policy makers, funders, and publishers to judge their quality.• Following our step-by-step guide will help reviewers and users of IPD meta-analyses to understand them better and recognise those that are well designed and conducted and so help ensure that policy, practice, and research are informed by robust evidence about the effects of interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689 · cited 1×
“, Peto, MantelHaenszel, and inverse-variance [44,45]) and random effects methods (e.”
MethodSterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1×
“Funnel plots may also help indicate the potential impact of both known and unknown missing trials on the results [25] but would not be appropriate in a meta-analysis including less than ten trials [25] or few trials with statistically significant results or one in which heterogeneity has been observed [26].”
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309 · cited 1×
“If patients drop out or are excluded from the analysis of a trial in considerable numbers and/or disproportionately by arm, this can cause attrition bias (Table 2, [36]), particularly if the reasons are related to the intervention and outcome.”
BackgroundBeta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205 · cited 1×
“, Peto, MantelHaenszel, and inverse-variance [44,45]) and random effects methods (e.”
Method
Cited by
Buffart, L. M., Kalter, J., Sweegers, M. G., Courneya, K. S., Newton, R. U., Aaronson, N. K., Jacobsen, P. B., May, A. M., Galvão, D. A., Chinapaw, M. J., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.010 · Cited by 595
“Meta-analyses based on aggregate data are limited to using summary data, such as the mean age of the patients or the proportion of men in a study, and they are unable to investigate intervention-covariate interactions at the level of the patient [16,17].”
Riley, R. D., Ensor, J., Snell, K. I. E., Debray, T. P. A., Altman, D. G., Moons, K. G. M., & Collins, G. S. (2016) · BMJ · doi:10.1136/bmj.i3140 · Cited by 585
Self-citationBurke, D. L., Ensor, J., & Riley, R. D. (2017) · Statistics in Medicine · doi:10.1002/sim.7141 · Cited by 538
Self-citationRomero, R., Conde-Agudelo, A., Da Fonseca, E., O’Brien, J. M., Cetingoz, E., Creasy, G. W., Hassan, S. S., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.576 · Cited by 522
ECMO for severe ARDS: systematic review and individual patient data meta-analysis
Combes, A., Peek, G. J., Hajage, D., Hardy, P., Abrams, D., Schmidt, M., Dechartres, A., & Elbourne, D. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06248-3 · Cited by 428
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa029 · Cited by 425
Vale, C. L., Fisher, D., Kneebone, A., Parker, C., Pearse, M., Richaud, P., Sargos, P., Sydes, M. R., Brawley, C., Brihoum, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31952-8 · Cited by 404
Self-citationGayet-Ageron, A., Prieto-Merino, D., Ker, K., Shakur, H., Ageron, F.-X., Roberts, I., Kayani, A., Geer, A., Ndungu, B., Fawole, B., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32455-8 · Cited by 396
Rogozińska, E., Marlin, N., Jackson, L., Rayanagoudar, G., Ruifrok, A. E., Dodds, J., Molyneaux, E., van Poppel, M. N., Poston, L., Vinter, C. A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21410 · Cited by 298
Self-citationMataix-Cols, D., Fernández de la Cruz, L., Monzani, B., Rosenfield, D., Andersson, E., Pérez-Vigil, A., Frumento, P., de Kleine, R. A., Difede, J., Dunlop, B. W., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3955 · Cited by 288
Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure
Taylor, R. S., Walker, S., Smart, N. A., Piepoli, M. F., Warren, F. C., Ciani, O., Whellan, D., O’Connor, C., Keteyian, S. J., Coats, A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.072 · Cited by 283
Hardwicke, T. E., Wallach, J. D., Kidwell, M. C., Bendixen, T., Crüwell, S., & Ioannidis, J. P. A. (2020) · Royal Society Open Science · doi:10.1098/rsos.190806 · Cited by 217
Hardwicke, T. E., Thibault, R. T., Kosie, J. E., Wallach, J. D., Kidwell, M. C., & Ioannidis, J. P. A. (2022) · Perspectives on Psychological Science · doi:10.1177/1745691620979806 · Cited by 187
Flückiger, C., Rubel, J., Del Re, A. C., Horvath, A. O., Wampold, B. E., Crits-Christoph, P., Atzil-Slonim, D., Compare, A., Falkenström, F., Ekeblad, A., et al. (2020) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000594 · Cited by 180
Conde-Agudelo, A., Romero, R., Da Fonseca, E., O’Brien, J. M., Cetingoz, E., Creasy, G. W., Hassan, S. S., Erez, O., Pacora, P., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.03.028 · Cited by 168
“In the first stage, estimates of effect were derived from the IPD for each trial, and in the second stage, these were combined using standard methods for meta-analyses of aggregate data to give a pooled RR with 95% CI.(103) A similar approach was used in the IPD meta-analysis of trials that evaluated cerclage versus n…”
Collaborators, T. R. A. R. O. P. W. A. A. S. (., Brady, M. C., Ali, M., VandenBerg, K., Williams, L. J., Williams, L. R., Abo, M., Becker, F., Bowen, A., Brandenburg, C., et al. (2022) · Stroke · doi:10.1161/strokeaha.121.035216 · Cited by 131
Galante, J., Friedrich, C., Collaboration of Mindfulness Trials (CoMinT), Aeamla-Or, N., Arts-de Jong, M., Barrett, B., Bögels, S. M., Buitelaar, J. K., Checovich, M. M., Christopher, M. S., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00081-5 · Cited by 113
“We were able to obtain IPD for 96% of the eligible participants, over the 90% mark which is seen as a reliable indicator of low risk of selection bias 86,87 .”
Sweegers, M. G., Altenburg, T. M., Brug, J., May, A. M., van Vulpen, J. K., Aaronson, N. K., Arbane, G., Bohus, M., Courneya, K. S., Daley, A. J., et al. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-099191 · Cited by 109
Calibrating the Scientific Ecosystem Through Meta-Research
Hardwicke, T. E., Serghiou, S., Janiaud, P., Danchev, V., Crüwell, S., Goodman, S. N., & Ioannidis, J. P. A. (2020) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-031219-041104 · Cited by 98
Panagioti, M., Bower, P., Kontopantelis, E., Lovell, K., Gilbody, S., Waheed, W., Dickens, C., Archer, J., Simon, G., Ell, K., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1794 · Cited by 94
Reflections on the history of systematic reviews
Clarke, M., & Chalmers, I. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-110968 · Cited by 81
Self-citationJonkman, N., Westland, H., Trappenburg, J. C., Groenwold, R. H., Bischoff, E. W., Bourbeau, J., Bucknall, C. E., Coultas, D., Effing, T. W., Epton, M., et al. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s107884 · Cited by 71
Tan, A. C., Askie, L. M., Hunter, K. E., Barba, A., Simes, R. J., & Seidler, A. L. (2021) · Research Synthesis Methods · doi:10.1002/jrsm.1500 · Cited by 48
Collaborators, T. R., Brady, M. C., Ali, M., VandenBerg, K., Williams, L. J., Williams, L. R., Abo, M., Becker, F., Bowen, A., Brandenburg, C., et al. (2022) · International Journal of Stroke · doi:10.1177/17474930221097477 · Cited by 54
“…data meta-syntheses include the risk of outcome reporting bias, 10 restricted inclusion of language data, and the need to synthesize various clinical language assessments into a standardized mean difference 11,12 , making clinical interpretation and application of emerging evidence a challenge.”
BackgroundA framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials.
Tierney, J. F., Fisher, D. J., Vale, C. L., Burdett, S., Rydzewska, L. H., Rogozińska, E., Godolphin, P. J., White, I. R., & Parmar, M. K. B. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003629 · Cited by 31
“To date, most PMAs have been based on individual participant data (IPD), which brings additional advantages, such as the ability to include more outcomes, standardise their definitions, and carry out more in-depth analyses, including investigation of subgroup effects [7,8].”
BackgroundSelf-citationKaufmann, E., Reips, U.-D., & Maag Merki, K. (2016) · Zeitschrift für Psychologie · doi:10.1027/2151-2604/a000251 · Cited by 31
“(For an overview of possible biases in meta-analysis, see Tierney et al., 2015.)”
BackgroundMethodA critical view on primary and secondary outcome measures in nutrition trials
Arabi, Y. M., & Preiser, J.-C. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4894-x · Cited by 26
Systematic reviews and meta-analysis in rheumatology: a gentle introduction for clinicians
Kelley, G. A., & Kelley, K. S. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04590-6 · Cited by 8
Metadata
- Authors
- Tierney, J. F., Vale, C., Riley, R., Smith, C. T., Stewart, L., Clarke, M., & Rovers, M.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-07-21
- Volume
- 12
- Issue
- 7
- Pages
- e1001855
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W1923600032
- Cited by
- 361
- References
- 73
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.